154 related articles for article (PubMed ID: 3308292)
1. Monitoring aminoglycoside therapy.
Mullins RE; Lampasona V; Conn RB
Clin Lab Med; 1987 Sep; 7(3):513-29. PubMed ID: 3308292
[TBL] [Abstract][Full Text] [Related]
2. Molecular understanding of aminoglycoside action and resistance.
Jana S; Deb JK
Appl Microbiol Biotechnol; 2006 Mar; 70(2):140-50. PubMed ID: 16391922
[TBL] [Abstract][Full Text] [Related]
3. [Aminoglycoside-induced nephrotoxicity].
Fabrizii V; Thalhammer F; Hörl WH
Wien Klin Wochenschr; 1997 Nov; 109(21):830-5. PubMed ID: 9454436
[TBL] [Abstract][Full Text] [Related]
4. [Tobramycin--clinical pharmacology and chemotherapy].
Periti P
J Chemother; 1996 Jan; 8 Suppl 1():3-30. PubMed ID: 8948764
[TBL] [Abstract][Full Text] [Related]
5. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.
Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ
Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955
[TBL] [Abstract][Full Text] [Related]
6. R-factors in gram-positive and gram-negative aerobic bacteria selected by antimicrobial therapy.
Buu-Hoi A; Goldstein FW; Acar JF
Scand J Infect Dis Suppl; 1986; 49():46-55. PubMed ID: 3547625
[TBL] [Abstract][Full Text] [Related]
7. Exploration of once-daily dosing of aminoglycosides through Bayesian simulation.
Garrelts JC
Pharmacotherapy; 1996; 16(2):286-94. PubMed ID: 8820474
[TBL] [Abstract][Full Text] [Related]
8. Controversies in antimicrobial therapy: pitfalls in monitoring aminoglycoside therapy.
Fant WK
Am J Hosp Pharm; 1986 Mar; 43(3):641-6. PubMed ID: 3706319
[TBL] [Abstract][Full Text] [Related]
9. Nosocomial infections due to gram-negative bacilli in compromised hosts: considerations for prevention and therapy.
Klastersky J
Rev Infect Dis; 1985; 7 Suppl 4():S552-8. PubMed ID: 3909312
[TBL] [Abstract][Full Text] [Related]
10. Resistance to aminoglycoside antibiotics of gram-negative bacilli isolated in Canadian hospitals.
Duncan IB; Cheung EY; Haldane EV; Jackson FL; McNaughton RD; Morisset RA; Noble MA; Rennie RP; Ronald AR; Smith JA
Can Med Assoc J; 1981 May; 124(9):1165-7. PubMed ID: 7237336
[TBL] [Abstract][Full Text] [Related]
11. The most frequently occurring aminoglycoside resistance mechanisms--combined results of surveys in eight regions of the world. The Aminoglycoside Resistance Study Groups.
J Chemother; 1995 Jun; 7 Suppl 2():17-30. PubMed ID: 8622108
[TBL] [Abstract][Full Text] [Related]
12. Use of aminoglycosides in elderly patients. Pharmacokinetic and clinical considerations.
Mörike K; Schwab M; Klotz U
Drugs Aging; 1997 Apr; 10(4):259-77. PubMed ID: 9108987
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of the etiological structure and dynamics of antibiotic resistance in the causative agents of suppurative inflammatory diseases in the patients at a large general hospital].
Kuznetsova SM; Samoĭlova LN; Speranskaia ON; Abadzhieva AN; Fomina IP
Antibiotiki; 1984 Aug; 29(8):605-13. PubMed ID: 6486756
[TBL] [Abstract][Full Text] [Related]
14. The role of aminoglycosides in modern therapy.
Beaucaire G
J Chemother; 1995 Jun; 7 Suppl 2():111-23. PubMed ID: 8622100
[TBL] [Abstract][Full Text] [Related]
15. Single daily dosing of aminoglycosides.
Preston SL; Briceland LL
Pharmacotherapy; 1995; 15(3):297-316. PubMed ID: 7667165
[TBL] [Abstract][Full Text] [Related]
16. Current use of aminoglycosides: indications, pharmacokinetics and monitoring for toxicity.
Avent ML; Rogers BA; Cheng AC; Paterson DL
Intern Med J; 2011 Jun; 41(6):441-9. PubMed ID: 21309997
[TBL] [Abstract][Full Text] [Related]
17. [Current state of antibiotic resistance of pathogenic aerobic bacteria in Hungary].
Konkoly T; Marianne ; Bán E
Orv Hetil; 1986 Apr; 127(17):995-1001. PubMed ID: 3703555
[No Abstract] [Full Text] [Related]
18. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
19. [Bacteremias in a university hospital: study of etiologic agents and their sensitivity patterns].
Betriu C; Palau L; Gómez M; Sánchez A; Romero J; Picazo JJ
Rev Clin Esp; 1999 Aug; 199(8):503-10. PubMed ID: 10522430
[TBL] [Abstract][Full Text] [Related]
20. Strategy of antibiotic rotation: long-term effect on incidence and susceptibilities of Gram-negative bacilli responsible for ventilator-associated pneumonia.
Gruson D; Hilbert G; Vargas F; Valentino R; Bui N; Pereyre S; Bebear C; Bebear CM; Gbikpi-Benissan G
Crit Care Med; 2003 Jul; 31(7):1908-14. PubMed ID: 12847382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
